Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00949390 · ClinicalTrials.gov registry record
Complementary and Alternative Medicine Usage Among Participants Enrolled in Phase I Oncology Clinical Trials
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 309
- Enrollment target
NCT00949390: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT00949390 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 309 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00949390 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 309 participants
- Enrollment target
Study Summary
Primary Objective: · The primary objective is to estimate the prevalence of use of complementary and alternative medicine (CAM) in patients with advanced malignancies who are seen in the Phase I clinic at MD Anderson Cancer Center (MDACC). Secondary Objective: · Examine the association between prevalence of CAM use and demographic and socioeconomic characteristics (age, gender, race, income, and education level), participation in a phase I clinical trial, disease characteristics (diagnosis), patients' perceptions about their prognosis, physicians' information and permission for patients' CAM use, decision-making, and types of CAM used by patients.
Interventions
- BEHAVIORAL Questionnaire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 309 participants |
| Start Date | 2009-07 |
| Est. Completion | 2016-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00949390
The ClinicalTrials.gov registry entry for NCT00949390 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 309 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Questionnaire is the first listed.
NCT00949390 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00949390 about?
NCT00949390 is a clinical study titled "Complementary and Alternative Medicine Usage Among Participants Enrolled in Phase I Oncology Clinical Trials". Primary Objective: · The primary objective is to estimate the prevalence of use of complementary and alternative medicine (CAM) in patients with advanced malignancies who are seen in the Phase I clinic at MD Anderson Cancer Center (MDACC). Secondary Objective: · Examine the association between pr...
What is the current status of trial NCT00949390?
This trial is currently completed. The enrollment target is 309 participants. The study started on 2009-07. Estimated completion is 2016-04.
What interventions are being tested in trial NCT00949390?
The interventions under investigation include: Questionnaire (BEHAVIORAL).
Who is sponsoring clinical trial NCT00949390?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.